Detalhe da pesquisa
1.
Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype.
Cancer Cell Int
; 19: 112, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164793
2.
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Mol Cancer
; 16(1): 26, 2017 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143614
3.
Deciphering the function of non-coding RNAs in prostate cancer.
Cancer Metastasis Rev
; 35(2): 235-62, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221068
4.
MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.
Br J Cancer
; 116(5): 634-639, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081549
5.
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
J Cell Mol Med
; 18(11): 2287-97, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211630
6.
Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.
J Cell Mol Med
; 17(8): 1048-58, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23890189
7.
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Genes Chromosomes Cancer
; 51(3): 240-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22081504
8.
High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Breast Cancer Res Treat
; 129(1): 1-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20842524
9.
Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.
BMC Cancer
; 10: 470, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20809970
10.
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
Front Oncol
; 9: 900, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31572685
11.
Methylation-Specific PCR.
Methods Mol Biol
; 1708: 447-472, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29224158
12.
High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
Urol Oncol
; 36(4): 161.e7-161.e17, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174711
13.
A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.
Clin Epigenetics
; 10: 40, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599847
14.
Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.
J Hematol Oncol
; 10(1): 43, 2017 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28166834
15.
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Cancer Lett
; 385: 150-159, 2017 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984115
16.
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer.
Oncotarget
; 7(33): 53018-53028, 2016 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27323813
17.
Prognostic significance of MST1R dysregulation in renal cell tumors.
Am J Cancer Res
; 6(8): 1799-811, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648366
18.
MicroRNA-375 plays a dual role in prostate carcinogenesis.
Clin Epigenetics
; 7: 42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977730
19.
Deregulated expression of selected histone methylases and demethylases in prostate carcinoma.
Endocr Relat Cancer
; 21(1): 51-61, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24200674
20.
Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Curr Pharm Des
; 20(11): 1803-11, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23888969